Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2024/03/26?limit=200®isters=between&mode=atom2025-01-09T09:11:51-08:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06424.htmlNotice - Announcement of the Advisory Panel on Outreach and Education (APOE) In-Person Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06424Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06424.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06316.htmlNotice - Agency Information Collection Activities; Proposed Collection; Comment Request; National Agriculture and Food Defense Strategy Survey2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06316Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06316.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06405.htmlNotice - Advisory Council on Alzheimer's Research, Care, and Services; Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06405Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06405.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06366.htmlNotice - Agency Information Collection Activities: Proposed Collection; Public Comment Request; for the State Plan of Assistive Technology (OMB Control Number 0985-0048)2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06366Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06366.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06395.htmlNotice - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Reporting and Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material From Cattle2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06395Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06395.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06265.htmlNotice - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06265Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06265.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06037.htmlProposed Rule - Banned Devices; Proposal To Ban Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06037Proposed Rulehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06037.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06299.htmlNotice - Clovis Oncology, Inc., AstraZeneca Pharmaceuticals LP, and GlaxoSmithKline LLC; Withdrawal of Approval of the Indications for Advanced Ovarian Cancer for Poly (ADP-Ribose) Polymerase Inhibitors RUBRACA (Rucaparib) Tablets, LYNPARZA (Olaparib) Tablets, and ZEJULA (Niraparib) Capsules2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06299Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06299.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06298.htmlNotice - AstraZeneca Pharmaceuticals LP; Withdrawal of Approval of New Drug Application for LYNPARZA (Olaparib) Capsules2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06298Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06298.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06294.htmlNotice - Electronic Submissions: Data Standards; Support and Requirement for the Clinical Data Interchange Standards Consortium Standard for Exchange of Nonclinical Data Implementation Guide-Animal Rule Version 1.02024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06294Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06294.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06291.htmlNotice - Center for Scientific Review; Notice of Closed Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06291Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06291.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06287.htmlNotice - Phillip Leonowens: Final Debarment Order2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06287Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06287.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06286.htmlNotice - Center for Scientific Review; Notice of Closed Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06286Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06286.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06315.htmlNotice - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06315Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06315.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06314.htmlNotice - Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Use of Minimal Residual Disease as an Endpoint in Multiple Myeloma Clinical Trials2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06314Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06314.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06311.htmlNotice - Determination That ISUPREL (Isoproterenol Hydrochloride) Injection, 0.2 Milligrams per Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06311Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06311.pdfhttps://regulations.justia.com/regulations/fedreg/2024/03/26/2024-06304.htmlNotice - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-PAR 20-280, Cooperative Research Agreements Related to the World Trade Center Health Program (U01); RFA-OH-24-002, Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21); RFA-OH-24-003, Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications With Responders Accepted); and RFA-OH-24-004, World Trade Center Health Program Mentored Research Scientist Career Development Award (K01); Cancellation of Meeting2024-03-26T00:00:00-07:002024-03-26T00:00:00-07:002024-06304Noticehttps://www.govinfo.gov/content/pkg/FR-2024-03-26/pdf/2024-06304.pdf